APP and amyloidosis: This study assessed the potential of three categories of agents with known but different mechanisms of action, (1) conventional AEDs, (2) ACh and GABA modulating drugs, and (3) metabolic compounds, to suppress the occurrence of SWDs in aged APP/PS1 mice with fully developed amyloid plaque pathology.